Author Archive for Insider Scoop

4 Energy Stocks Moving In Monday’s After-Market Session

Courtesy of Benzinga

Gainers

SAExploration Holdings, Inc. (NASDAQ:SAEX) stock moved upwards by 6.3% to $2.77 during Monday’s after-market session.

Abraxas Petroleum, Inc. (NASDAQ:AXAS) stock surged 6.2% to $0.30. According to the most recent rating by Johnson Rice, on November 19, the current rating is at Accumulate.

Pacific Drilling, Inc. (NYSE:PACD) stock increased by 4.7% to $1.80. The most recent rating by Fearnleys, on November 07, is at Buy, with a price target of $7.00.

Antero Midstream, Inc. (NYSE:AM) stock increased by 3.7% to $6.38. The most recent rating by Citigroup, on January 27, is at Buy, with a price target of $7.00.

 





BofA Downgrades Wynn Resorts On Wuhan Coronavirus Concerns

Courtesy of Benzinga

BofA Downgrades Wynn Resorts On Wuhan Coronavirus Concerns

After initially dismissing the potential impact of the Wuhan coronavirus on Macau gaming stocks, one Wall Street analyst downgraded Wynn Resorts, Limited (NASDAQ: WYNN) on Monday due to concerns over the virus’ potential impact on Macau travel.

The Analyst

Bank of America analyst Shaun Kelley downgraded Wynn from Buy to Neutral and cut his price target from $160 to $150.

The Thesis

Kelley said Wynn’s exposure to international travel and the poor timing of the Wuhan outbreak just prior to the Chinese New Year holiday is enough for investors to take a cautious approach to Wynn for now.

Kelley said that, while the Wuhan virus appears to be less deadly than SARS, it now seems to be more contagious than experts initially believed.

“What is known about the disease, its curability and how it spreads is still limited but as we learn more, the virus appears to be more difficult to combat than expected, esp. as it may be contagious during its incubation period (unlike SARS),” Kelley wrote in a note.

The good news for Macau investors is that, while SARS originated in Southeast China, Wuhan is located about 600 miles from Macau. Out of more than 2,500 confirmed cases of the virus, only 8 cases have occurred in Hong Kong and just five so far in Macau.

Kelley said the Wuhan virus sell-off may ultimately be a buying opportunity for Macau gaming investors, near-term headline risk is significant and Wynn and competitor Las Vegas Sands Corp. (NYSE: LVS) have limited valuation support.

Benzinga’s Take

The good news for long-term investors is that the mortality rate of the Wuhan virus is under 3% up to this point compared to a more than 9% mortality rate for SARS. Thee SARS outbreak ultimately lasted about four months, and the S&P 500 gained 18.6% in the six months that followed.

Do you agree or disagree with these predictions? Email feedback@benzinga.com with your thoughts.

Related Links:

A History Of Coronavirus Outbreaks And The Stock Market

Analyst: Casino Sell-Offs ‘Could Be An Overreaction’ To Wuhan Coronavirus

Latest Ratings for WYNN

Date Firm Action From To
Jan 2020 Downgrades Buy Neutral
Jan 2020 Maintains Buy
Jan 2020 Maintains Equal-Weight

View More Analyst Ratings for WYNN


View the Latest Analyst Ratings

Posted-In: Bank of America coronavirus Macau Shaun KelleyAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga





Benzinga’s Top Upgrades, Downgrades For January 27, 2020

Courtesy of Benzinga

Upgrades

  • Evercore ISI Group upgraded the stock for NiSource Inc (NYSE: NI) from In-Line to Outperform. In the third quarter, NiSource showed an EPS of $0.00, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $30.67 and a 52-week-low of $25.91. NiSource’s stock last closed at $29.07 per share.
  • Evercore ISI Group changed the rating for Pinnacle West Capital Corp (NYSE: PNW) from Underperform to In-Line. In the third quarter, Pinnacle West Capital showed an EPS of $2.77, compared to $2.80 from the year-ago quarter. The stock has a 52-week-high of $99.81 and a 52-week-low of $84.26. Pinnacle West Capital’s stock last closed at $97.16 per share.
  • Evercore ISI Group upgraded the stock for DTE Energy Co (NYSE: DTE) from In-Line to Outperform. For the third quarter, DTE Energy had an EPS of $1.91, compared to year-ago quarter EPS of $2.13. The stock has a 52-week-high of $134.72 and a 52-week-low of $112.86. DTE Energy’s stock last closed at $132.77 per share.
  • For CenterPoint Energy Inc (NYSE: CNP), Evercore ISI Group upgraded the stock from In-Line to Outperform. In the third quarter, CenterPoint Energy showed an EPS of $0.53, compared to $0.39 from the year-ago quarter. The stock has a 52-week-high of $31.42 and a 52-week-low of $24.25. CenterPoint Energy’s stock last closed at $26.47 per share.
  • DA Davidson upgraded the stock for Nordson Corp (NASDAQ: NDSN) from Neutral to Buy. In the fourth quarter, Nordson showed an EPS of $1.79, compared to $1.44 from the year-ago quarter. The stock has a 52-week-high of $173.40 and a 52-week-low of $124.48. Nordson’s stock last closed at $170.98 per share.
  • Stephens & Co. changed the rating for U.S. Xpress Enterprises Inc (NYSE: USX) from Equal-Weight to Overweight. In the third quarter, U.S. Xpress Enterprises showed an EPS of ($0.03), compared to $0.33 from the year-ago quarter. The stock has a 52-week-high of $9.87 and a 52-week-low of $3.37. U.S. Xpress Enterprises’s stock last closed at $5.34 per share.
  • BMO Capital changed the rating for S&P Global Inc (NYSE: SPGI) from Market Perform to Outperform. For the third quarter, S&P Global had an EPS of $2.46, compared to year-ago quarter EPS of $2.11. The stock has a 52-week-high of $299.59 and a 52-week-low of $185.08. S&P Global’s stock last closed at $294.83 per share.
  • Wedbush upgraded the stock for Chewy Inc (NYSE: CHWY) from Neutral to Overweight. In the third quarter, Chewy earned ($0.20). The stock has a 52-week-high of $41.34 and a 52-week-low of $21.68. Chewy’s stock last closed at $28.45 per


continue reading





20 Healthcare Stocks Moving In Monday’s Pre-Market Session

Courtesy of Benzinga

Gainers

Lianluo Smart, Inc. (NASDAQ:LLIT) stock rose 51.4% to $1.65 during Monday’s pre-market session.

Co-Diagnostics, Inc. (NASDAQ:CODX) stock rose 48.9% to $2.80.

Allied Healthcare Prods, Inc. (NASDAQ:AHPI) shares moved upwards by 36.5% to $3.96.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares rose 28.8% to $5.46. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock rose 21.2% to $1.60.

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares surged 19.3% to $1.06.

Novavax, Inc. (NASDAQ:NVAX) stock rose 18.2% to $9.22.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares surged 16.6% to $7.15.

Aethlon Medical, Inc. (NASDAQ:AEMD) stock surged 15.8% to $2.78.

Vaxart, Inc. (NASDAQ:VXRT) shares moved upwards by 15.4% to $0.57.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares surged 10.3% to $3.10. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.

Losers

NeuroMetrix, Inc. (NASDAQ:NURO) stock plummeted 26.1% to $3.51 during Monday’s pre-market session.

Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) stock declined 11.7% to $1.44.

Innovate, Inc. (NASDAQ:INNT) shares fell 9.9% to $0.75.

Genprex, Inc. (NASDAQ:GNPX) shares fell 7.8% to $1.18.

Mallinckrodt, Inc. (NYSE:MNK) stock fell 7.2% to $4.80.

Cronos Group, Inc. (NASDAQ:CRON) shares decreased by 6.1% to $7.12. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.

SmileDirectClub, Inc. (NASDAQ:SDC) stock plummeted 5.1% to $12.40. The most recent rating by Wolfe Research, on January 09, is at Underperform, with a price target of $7.00.

Endo International, Inc. (NASDAQ:ENDP) stock plummeted 4.9% to $5.63. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $7.00.

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shares plummeted 4.7% to $4.07.





10 Medical Instruments & Supplies Stocks Moving In Monday’s Session

Courtesy of Benzinga

Gainers

Antares Pharma, Inc. (NASDAQ:ATRS) stock surged 3.4% to $4.12 during Monday’s regular session.

Losers

NeuroMetrix, Inc. (NASDAQ:NURO) stock decreased by 29.0% to $3.37 during Monday’s regular session.

Akers Biosciences, Inc. (NASDAQ:AKER) stock declined 7.8% to $2.95.

Staar Surgical, Inc. (NASDAQ:STAA) shares declined 4.0% to $37.10. The most recent rating by BTIG, on December 04, is at Buy, with a price target of $46.00.

Intuitive Surgical, Inc. (NASDAQ:ISRG) shares plummeted 3.9% to $566.02. The most recent rating by Deutsche Bank, on January 27, is at Hold, with a price target of $595.00.

Valeritas Holdings, Inc. (NASDAQ:VLRX) stock declined 3.8% to $0.64. According to the most recent rating by Oppenheimer, on December 23, the current rating is at Perform.

Nephros, Inc. (NASDAQ:NEPH) shares decreased by 3.5% to $9.31.

Microbot Medical, Inc. (NASDAQ:MBOT) stock fell 3.4% to $9.98. The most recent rating by H.C. Wainwright, on January 13, is at Buy, with a price target of $26.00.

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares plummeted 3.3% to $0.36.

Predictive Oncology, Inc. (NASDAQ:POAI) stock declined 3.2% to $2.75.





4 Electronic Gaming & Multimedia Stocks Moving In Monday’s Session

Courtesy of Benzinga

Gainers

RealNetworks, Inc. (NASDAQ:RNWK) shares surged 3.4% to $1.52 during Monday’s regular session.

Losers

Super League Gaming, Inc. (NASDAQ:SLGG) stock plummeted 5.0% to $2.85 during Monday’s regular session. The most recent rating by Stephens & Co., on December 18, is at Equal-Weight, with a price target of $3.00.

SciPlay, Inc. (NASDAQ:SCPL) stock declined 3.2% to $11.47. According to the most recent rating by DA Davidson, on January 22, the current rating is at Buy.

Sea, Inc. (NYSE:SE) stock decreased by 3.0% to $43.95. The most recent rating by Goldman Sachs, on January 22, is at Buy, with a price target of $50.00.





6 Waste Management Stocks Moving In Monday’s Session

Courtesy of Benzinga

Gainers

TMSR Holding Co, Inc. (NASDAQ:TMSR) stock moved upwards by 6.6% to $1.83 during Monday’s regular session.

Sharps Compliance, Inc. (NASDAQ:SMED) stock moved upwards by 3.4% to $4.52.

Losers

Estre Ambiental, Inc. (NASDAQ:ESTR) stock declined 9.2% to $0.26 during Monday’s regular session.

Newater Technology, Inc. (NASDAQ:NEWA) stock decreased by 4.2% to $3.77.

Charah Solutions, Inc. (NYSE:CHRA) shares plummeted 3.3% to $2.75.

Aqua Metals, Inc. (NASDAQ:AQMS) shares declined 3.3% to $0.75. According to the most recent rating by Alliance Global Partners, on December 03, the current rating is at Hold.





Coronavirus Link Sends This Nano-Cap Stock Up 150%

Courtesy of Benzinga

Coronavirus Link Sends This Nano-Cap Stock Up 150%

Shares of nano-cap Cleveland BioLabs, Inc. (NASDAQ: CBLI) jumped out of the gate at Monday’s open and are sustaining the strong momentum on over 100 times their average volume.

The strong move came amid a lack of any significant news from the company. It’s apparently in reaction to the coronavirus outbreak in China, which has thus far claimed 80 lives and left about 461 in critical condition.

Cleveland BioLabs neither has any coronavirus drug or vaccine in its pipeline nor an experimental one targeting the deadly disease.

The company’s most advanced pipeline asset is entolimod, which is in Phase 1 development as a radiation countermeasure and as an immunotherapy for oncology and other indications.

Apart from another experimental drug CBLB612, which is being evaluated for chemotherapy-induced myelosuppression, Cleveland BioLabs has an adjuvant vaccine candidate codenamed SA-701 in early-stage of development. Vaccine adjuvants are chemical substances that may be added to vaccines to boost the immune response.

SA-701 is being evaluated for multiple indications namely addiction, infection and cancer.

Cleveland BioLabs joins a host of companies that have capitalized on the coronavirus frenzy, thanks to their product candidates/techniques that could came in handy for screening and preventing or tackling the infection.

Cleveland BioLabs shares are soaring 165% to $3.50 at time of publication.

See Also:

BofA Downgrades Wynn Resorts On Wuhan Coronavirus Concerns

Johnson & Johnson Is ‘Confident’ In Ability To Treat Coronavirus, But Vaccine Could Take Time

Posted-In: coronavirus Wuhan coronavirusBiotech Penny Stocks Markets Movers Trading Ideas General Best of Benzinga





A Bull Vs. Bear Take On Apple’s Stock

Courtesy of Benzinga

A Bull Vs. Bear Take On Apple's Stock

Over the past year, Apple Inc. (NASDAQ: AAPL) shares have risen more than 100%, trading from the $150 level to hitting an all-time high north of $315 per share earlier this month. Despite the strong performance, there are some analysts with mixed outlooks.

Based on 33 analysts with a 12-month price target, the average price target on Apple’s stock is $303.50, with a high of $400 and a low of $188, according to TipRanks.

Here is a bullish and bearish argument from two analysts.

The Apple Bear

On Dec. 17, Rosenblatt Securities analyst Jun Zhang maintained a Sell rating on Apple’s stock.

“We believe iPhone 11 sales were strong in China in November; however, the cheaper retail price of the iPhone 11 has driven consumers to buy the iPhone 11 instead of the iPhone 11 Pro and all older models,” the analyst said at the time.

The firm expects overall iPhone production to drop 40-50% quarter-over-quarter.

“We expect more production cuts in March as Apple will see increasing headwinds from aggressive 5G smartphone launches in China and 5G service promotions in China begin in March,” the analyst said.

Rosenblatt recently raised its price target from $150 to $250, but maintained its Sell rating.

See Also: Great American Companies: A Brief History Of Apple Inc.

The Apple Bull

On Jan. 16, Tigress Financial analyst Ivan Feinseth expressed his belief of further upside in Apple.

“Apple continues to benefit from a strong demand cycle for its iPhone 11 that will be followed by an upgrade supercycle later this year when it launches 5G-enabled iPhones,” the analyst said.

Feinseth also mentions the growth opportunity from the variety of services Apple provides.

“Growth in its Services, including Apple TV+, Apple Arcade, Apple News, Apple Pay, and the Apple Card, should exceed a $60+ billion run rate when Apple reports results,” the analyst said.

What’s Your Take On Apple?

Apple is scheduled to report first-quarter earnings after Tuesday’s market close. Analysts are looking for earnings of $4.54 per share on revenue of $88.39 billion.

Latest Ratings for AAPL

Date Firm Action From To
Jan 2020 Maintains Hold
Jan 2020 Maintains Outperform
Jan 2020 Maintains Outperform

View More Analyst Ratings for AAPL


View the Latest Analyst Ratings

Posted-In: bull versus bear debate Ivan FeinsethAnalyst Color Long Ideas Short Ideas Price Target Analyst Ratings Trading Ideas Best of Benzinga





15 Biotechnology Stocks Moving In Thursday’s After-Market Session

Courtesy of Benzinga

Gainers

Alector, Inc. (NASDAQ:ALEC) stock rose 10.8% to $25.79 during Thursday’s after-market session. The most recent rating by BTIG, on November 21, is at Buy, with a price target of $28.00.

Therapix Biosciences, Inc. (NASDAQ:TRPX) stock moved upwards by 6.1% to $0.61.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares increased by 5.7% to $2.80. The most recent rating by BMO Capital, on December 09, is at Outperform, with a price target of $8.00.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares surged 5.2% to $4.04. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares rose 5.1% to $2.25.

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) stock moved upwards by 5.0% to $0.20.

Heat Biologics, Inc. (NASDAQ:HTBX) stock rose 4.5% to $0.30.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares moved upwards by 4.2% to $3.59. According to the most recent rating by Gabelli & Co., on December 11, the current rating is at Hold.

Viking Therapeutics, Inc. (NASDAQ:VKTX) stock increased by 3.5% to $7.05.

Losers

Akero Therapeutics, Inc. (NASDAQ:AKRO) stock fell 6.1% to $23.00 during Thursday’s after-market session.

AC Immune, Inc. (NASDAQ:ACIU) shares plummeted 5.1% to $8.78. The most recent rating by H.C. Wainwright, on December 10, is at Buy, with a price target of $11.00.

Aquestive Therapeutics, Inc. (NASDAQ:AQST) stock declined 3.8% to $3.82. The most recent rating by BMO Capital, on January 13, is at Outperform, with a price target of $18.00.

ContraFect, Inc. (NASDAQ:CFRX) shares plummeted 3.6% to $1.08.

Applied Genetic Tech, Inc. (NASDAQ:AGTC) shares fell 3.5% to $8.08.

Verastem, Inc. (NASDAQ:VSTM) shares plummeted 3.1% to $1.88.





 
 
 

Zero Hedge

San Francisco Activates Emergency Operations Center To Prepare For Coronavirus 

Courtesy of ZeroHedge View original post here.

Increasing fears of coronavirus spreading across the U.S. have resulted in San Francisco Mayor London Breed to activate the city’s emergency operations center, reported the San Francisco Chronicle

“It’s, so we have a centralized location...



more from Tyler

Phil's Favorites

Coronavirus outbreak: WHO's decision to not declare a global public health emergency explained

 

Coronavirus outbreak: WHO's decision to not declare a global public health emergency explained

Masks are selling out in Singapore amid concerns about the Wuhan virus. Ng Sor Luan/EPA

Courtesy of Tom Solomon, University of Liverpool

The World Health Organization’s decision to not declare the novel coronavirus outbreak in China a public health emergency of international concern, or PHEIC, will surprise many. The number of reported cases and deaths is doubling every co...



more from Ilene

Insider Scoop

4 Energy Stocks Moving In Monday's After-Market Session

Courtesy of Benzinga

Gainers

SAExploration Holdings, Inc. (NASDAQ:SAEX) stock moved upwards by 6.3% to $2.77 during Monday's after-market session.

Abraxas Petroleum, Inc. (NASDAQ:AXAS) stock surged 6.2% to $0.30. According to the most recent rating by Johnson Rice, on November 19, the current rating is at Accumulate.

Pacific Drilling, Inc. (NYSE:PACD) stock increased by 4.7% to $1.80. The most recent rating by Fearnleys...



http://www.insidercow.com/ more from Insider

Chart School

Top Patterns for Retail Investors

Courtesy of Read the Ticker

Retail investors are last in line for market leading research, no matter, the retail investor can profit from these secret sauce patterns..

Well not so secret now, the main point is you do not have to climb Mount Everest to be called a mountain climber, there are many other hills to climb to make your mark. Just like stocks.

You do not have to battle with the high frequency traders to win in the markets, there are long and slow methods to do just as well.  

More from RTT Tv







Some charts from the video


...

more from Chart School

The Technical Traders

The Wuhan Wipeout - Could It Happen?

Courtesy of Technical Traders

News is traveling fast about the Corona Virus that originated in Wuhan, China. Two new confirmed cases in the US, one in Europe and hundreds in China. As we learn more about thispotential pandemic outbreak, we are learning that China did very little to contain this problem from the start. Now, quarantining two cities and trying to control the potential
outbreak, may become a futile effort.

In most of Asia, the Chinese New Year is already in full swing.  Hong Kong, China, Singapore, Malaysia, India and a host of other countries are already starting to celebrate the 7 to 10 day long New Year.  Millions of people have already traveled hundreds of thousands of miles to visit family...



more from Tech. Traders

Kimble Charting Solutions

Bad News For Crude Oil Should Come From This Pattern, Says Joe Friday

Courtesy of Chris Kimble

It’s a good idea for investors to be aware of key indicators and inter-market relationships.

Perhaps it’s watching the US Dollar as an indicator for precious metals or emerging markets. Or watching interest rates for the economy. Experience, history, and relationships matter. And it’s good to simply add these to our tool-kit.

Today, we look at another relationship that has signaled numerous stock market tops and bottoms over the years, and especially the past several months, Crude Oil.

When crude oil tops or bottoms, it seems that ...



more from Kimble C.S.

Biotech

Snakes could be the original source of the new coronavirus outbreak in China

Reminder: We are available to chat with Members, comments are found below each post.

 

Snakes could be the original source of the new coronavirus outbreak in China

Chinese cobra (Naja atra) with hood spread. Briston/Wikimedia, CC BY-SA

Haitao Guo, University of Pittsburgh; Guangxiang “George” Luo, Univers...



more from Biotech

Members' Corner

The War on All Fact People

 

David Brin shares an excerpt from his new book on the relentless war against democracy and how we can fight back. You can also read the first, second and final chapters of Polemical Judo at David's blog Contrary Brin.

The War on All Fact People 

Excerpted from David Brin's new book, the beginning of chapter 5, Polemical Judo: Memes...



more from Our Members

Lee's Free Thinking

Why Blaming the Repo Market is Like Blaming the Australian Bush Fires

 

Why Blaming the Repo Market is Like Blaming the Australian Bush Fires

Courtesy of  

The repo market problem isn’t the problem. It’s a sideshow, a diversion, and a joke. It’s a symptom of the problem.

Today, I got a note from Liquidity Trader subscriber David, a professional investor, and it got me to thinking. Here’s what David wrote:

Lee,

The ‘experts’ I hear from keep saying that once 300B more in reserves have ...



more from Lee

Digital Currencies

Cryptos Have Surged Since Soleimani Death, Bitcoin Tops $8,000

Courtesy of ZeroHedge View original post here.

Bitcoin is up over 15% since the assassination of Iran General Soleimani...

Source: Bloomberg

...topping $8,000 for the first time since before Thanksgiving...

Source: Bloomberg

Testing its key 100-day moving-average for the first time since October...

...



more from Bitcoin

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>